CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$84.08
+0.08 (+0.09%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+82.73%
1Y
+201.56%
YTD
+79.92%
Open$84.01
Previous Close$84.00
Day High$84.09
Day Low$83.99
52W High$84.00
52W Low$25.83
Volume—
Avg Volume3.45M
Market Cap8.87B
P/E Ratio—
EPS$-5.13
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.40
Above
SMA 200
$38.81
Above
RSI (14)
27.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-41.2% upside
Current
$84.08
$84.08
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.68M | 7.39M | 1.14B |
| Net Income | -525,217,900 | -402,191,874 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -578,905,378 | -467,931,684 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,181.07 | -0.91% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $256.74 | -0.09% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.59 | +0.17% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $26.54 | +1.30% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $72.63 | -6.00% | 12.1 | 32.02B |